Fresh Recalls

FDAClass II · Drug · Recall D-0527-2026 · Recalled May 20, 2026

Buprenorphine Hydrochloride recall — ENDO USA, Inc.

Agency report date: May 20, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
Buprenorphine Hydrochloride
Company / brand
ENDO USA
Lot / serial / date codes
Lot #: 84132, Exp 02/28/2027; 87693, Exp 03/31/2027
Distribution
USA Nationwide
Agency product description and boundaries

Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx only, Manufactured for: Endo USA, Malvern, PA 19855, NDC 42023-179-05.

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Crystallization; identified as Buprenorphine free base

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: Buprenorphine Hydrochloride recall status

3. Open the official notice or contact

Official recall ID
D-0527-2026
Brand
All ENDO USA recalls
Classification
Class II
Units affected
34,293 vials
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Rochester, MI, United States
Firm address
870 Parkdale Rd, 48307-1740

Identifying details (verbatim from the notice)

Product codes / lots
Lot #: 84132, Exp 02/28/2027; 87693, Exp 03/31/2027
Distribution
USA Nationwide
Firm notified the public via
Letter
FDA event ID
98610
Recall initiated
March 13, 2026
FDA classified
May 11, 2026
FDA report date
May 20, 2026

Other drug recalls from around the same time

Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked October 22, 2026 at 6:00 PM UTC. Record retrieved August 18, 2026 at 6:00 PM UTC.

Report a data error on this page